Official Publication of the Society for Laboratory Automation and Screening

This is a paid advertisement. As a subscriber to SLAS Point-to-Point enewsletter, you will receive occasional messages from one of our sponsors. You may unsubscribe from future sponsor emails by clicking here.

Disrupting Drug Discovery From Assay Development to Lead Compound

High-throughput screening remains one of the most powerful, unbiased approaches for small molecule drug discovery.

Today, the high-throughput screening toolbox features traditional label-dependent approaches and novel label-free technologies. Researchers select the most promising methodology based on assay sensitivity, data quality, costs, and speed.

However, for many years, drug discovery researchers have been forced to compromise certain scientific assay goals—sacrificing data quality and costs to achieve high-throughput labeled assays, sacrificing speed to use biochemically relevant reaction conditions with slow label-free readouts, or sacrificing optimal assay conditions to use rapid label-free readouts.

With new innovations in assay methodologies, scientists no longer have to make sacrifices to do quality drug discovery research. Learn the important considerations for choosing the best drug discovery methodology in this free white paper.

3440 South Dearborn Street  |  Suite 220S  |  Chicago, IL 60616

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063